Net profit of Glaxosmithkline Pharmaceuticals rose 45.75% to Rs 194.48 crore in the quarter ended March 2024 as against Rs 133.43 crore during the previous quarter ended March 2023. Sales rose 18.08% to Rs 929.80 crore in the quarter ended March 2024 as against Rs 787.45 crore during the previous quarter ended March 2023.

For the full year,net profit declined 3.39% to Rs 589.96 crore in the year ended March 2024 as against Rs 610.69 crore during the previous year ended March 2023. Sales rose 6.21% to Rs 3453.71 crore in the year ended March 2024 as against Rs 3251.72 crore during the previous year ended March 2023.

Particulars	Quarter Ended			Year Ended
?	Mar. 2024	Mar. 2023	% Var.	Mar. 2024	Mar. 2023	% Var.
Sales	929.80	787.45	18	3453.71	3251.72	6
OPM %	27.67	21.56	-	26.31	24.73	-
PBDT	286.32	196.75	46	1029.48	903.14	14
PBT	268.22	179.57	49	959.80	837.37	15
NP	194.48	133.43	46	589.96	610.69	-3

Powered by Capital Market - Live News